Boceprevir and Telaprevir: Clinical Efficacy, Safety and Drug-Drug Interactions

1. Foot B.S, Spooner L.M., Belliveau P.P. Boceprevir: a protease inhibitor for the treatment of chronic hepatitis C. Ann Pharmacother 2011; 45: 1085-1093.

2. Smith L.S., Nelson M. Naik S., Woten /. Telaprevir: an NS3/4A protease inhibitor for the treatment of chronic hepatitis C. Ann Pharmacother 2011; 45: 639-648.

3. Kiser J.J., Burton J.R., Anderson P.L., Everson G.T. Review and management of drug interactions with boceprevir and telaprevir. Hepatology 2012; 55: 1620-1628.

4. Rangnekar A.S., Fontana R./. Managing drug-drug interactions with boceprevir and telaprevir. Clinical Liver Disease 2012; 1: 36-40.

5. www.clinical trials.gov